Two additional dosage strengths of Stalevo (carbidopa/levodopa/entacapone tablets) are now available from Novartis. The 75mg and 125mg tablets will be available in addition to the 50mg, 100mg, 150mg, and 200mg dosage strengths already on the market.

Stalevo is indicated for the treatment of idiopathic Parkinson’s disease.

For more information call (800) 693-9993 or visit www.Stalevo.com.